| Overview |
| bs-2286R-Cy5.5 |
| DHRS3 Polyclonal Antibody, Cy5.5 Conjugated |
| WB, IF(IHC-P), IF(IHC-F), IF(ICC) |
| Human, Mouse, Rat, Cow, Pig, Rabbit |
| Specifications |
| Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human DHRS3 |
| 101-200/302 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 9249 |
| Cell membrane |
| DD83.1; Dehydrogenase/reductase SDR family member 3; EC 1.1.1.300; MGC125166; RDH17; Retinal short chain dehydrogenase/reductase 1; retSDR1; Rsdr1 antibody SDR family, member 3; SDR1; SDR16C1; Short-chain dehydrogenase/reductase 3; Short-chain dehydrogenase/reductase family, member 3. |
| DHRS3 belongs to the short-chain dehydrogenases/reductases (SDR) family. It catalyzes the reduction of all-trans-retinal to all-trans-retinol in the presence of NADPH. DHRS3 is located in a region of chromosome 1 which is often deleted in aggressive neuroblastoma tumors. There are two named isoforms. |
| Application Dilution |
| WB |
1:300-5000 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz